Table 4 Concerns of registered salespersons about drug sales

Unable to judge whether to recommend medical consultation

22

(10.6)

83

(40.1)

72

(34.8)

28

(13.5)

2

(1.0)

Unable to answer consumer’s questions about OTC drugs

18

(8.7)

74

(35.7)

55

(26.6)

49

(23.7)

11

(5.3)

Unable to explain well about the indications

20

(9.7)

87

(42.0)

52

(25.1)

40

(19.3)

8

(3.9)

Unable to explain well about the dosage

52

(25.1)

91

(44.0)

36

(17.4)

22

(10.6)

6

(2.9)

Unable to respond when a consumer says that side effects have occurred

12

(5.8)

34

(16.4)

61

(29.5)

67

(32.4)

33

(15.9)

Unable to answer questions about concomitant use with prescription drugs

16

(7.7)

19

(9.2)

33

(15.9)

77

(37.2)

62

(30.0)

Unable to answer questions about concomitant use with healthy foods

12

(5.8)

40

(19.3)

63

(30.4)

73

(35.3)

19

(9.2)

Unable to judge whether pregnant or breast-feeding women can use OTC drugs

14

(6.8)

54

(26.1)

54

(26.1)

68

(32.9)

17

(8.2)

Unable to judge whether infants or children can use OTC drugs

17

(8.2)

67

(32.4)

59

(28.5)

50

(24.2)

14

(6.8)

Unable to judge whether the elderly can use OTC drugs

16

(7.7)

51

(24.6)

52

(25.1)

70

(33.8)

18

(8.7)

Unable to explain well to foreigners about OTC drugs

14

(6.8)

24

(11.6)

32

(15.5)

58

(28.0)

79

(38.2)

Absence of pharmacist or other registered sales person who can resolve doubts

74

(35.7)

73

(35.3)

36

(17.4)

18

(8.7)

6

(2.9)

Unable to speak to consumers actively

80

(38.6)

76

(36.7)

39

(18.8)

9

(4.3)

3

(1.4)

Advice rejected by consumers

62

(30.0)

90

(43.5)

39

(18.8)

14

(6.8)

2

(1.0)

Unable to have confidence in his or her explanation

26

(12.6)

57

(27.5)

64

(30.9)

45

(21.7)

15

(7.2)

Unable to make consumers understand

29

(14.0)

90

(43.5)

76

(36.7)

11

(5.3)

1

(0.5)